Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H I - J - K - L - M N - O - P - Q - R - S T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter H

GENERIC NAME

TRADE NAME

CONDITION

STUDY CODE

STUDY NAME

ACCESS TO STUDY / PROTOCOL

ACCESS TO RESULTS

HDM2/ P53 ANTAGONIST

Not Marketed

Neoplasm malignant

TED12318

NA

NCT01636479

HISTAMINE H3 RECEPTOR ANTAGONIST

Not Marketed

Alzheimer's Disease

DRI10734

NA

NCT01266525

HUDS6-DM4 MAYTANSINOID LOADED ANTI-CA6 MAB

Not Marketed

Triple Negative Breast Cancer

ACT14884

NA

EudraCT: 2016-001962-27

HYDROXYCHLOROQUINE

Plaquenil

Systemic Lupus Erythematosus

EFC12368

NA

NCT01551069

HYDROXYCHLOROQUINE

Plaquenil

Coronavirus Infection

EFC16855

NA

NCT04333654

HYDROXYCHLOROQUINE

Plaquenil

Coronavirus Infection

EFC16858

NA

EudraCT: 2020-001270-29

HYALURONIC ACID WITH LIDOCAINE

Derma Gel Extra

Facial Wrinkles

DGE00105

NA

NCT00444626

HYLAN G-F 20

Not marketed

primary dysmenorrhea

LPS16145

NA

EudraCT: 2019-004138-41

HYLAN G-F 20

Synvisc-One

Osteoarthritis

EFC12791

NA

NCT01618708

HYLAN G-F 20

Synvisc-One

Osteoarthritis

EFC12723

C-SOUND

NCT03190369

HYLAN G-F 20

Synvisc

Osteoarthritis

SYNV00704

NA

NCT00131352

HYLAN G-F 20

Synvisc-One

Osteoarthritis

SYNV03809

OASIS

NCT02389452

HYLAN G-F 20

Synvisc-One

Osteoarthritis

SYNV04910

NA

NCT01618708

HYLAN G-F 20

Synvisc

Osteoarthritis

SYNVIL06244

NA

NCT01586338

References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted